SciRhom
PrivateLast Round
Series A
Jul 9, 2024
Total Funding Raised
$88.56M
Momentum Score
50 /100
Company Overview
SciRhom is a biotechnology company specializing in the development of therapeutic antibodies aimed at enhancing treatments for autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciRhom Comps
Public and private peers based on sector, stage, and business model.
SciRhom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 9, 2024 | ||||
| Seed | Jan 12, 2021 |
Key People
Founding team and executive leadership
SciRhom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Andera Partners | Series A |
| MIG AG | Series A |
| Ventura Ace | Seed |
| Hadean Ventures | Series A |
| Wellington Partners | Series A |
| Bayern Kapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Monthly visitors grew 92% MoM.
SciRhom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SciRhom's valuation, stock price, and market status.
